Wong LM - Search Results

1

Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma-The RAPPORT Trial.

Siva S, Bressel M, Wood ST, Shaw MG, Loi S, Sandhu SK, Tran B, A Azad A, Lewin JH, Cuff KE, Liu HY, Moon D, Goad J, Wong LM, LimJoon M, Mooi J, Chander S, Murphy DG, Lawrentschuk N, Pryor D. Siva S, et al. Among authors: wong lm. Eur Urol. 2022 Apr;81(4):364-372. doi: 10.1016/j.eururo.2021.12.006. Epub 2021 Dec 23. Eur Urol. 2022. PMID: 34953600 Clinical Trial.

2

Urinary catheter balloons should only be filled with water: testing the myth.

Huang JG, Ooi J, Lawrentschuk N, Chan ST, Travis D, Wong LM. Huang JG, et al. Among authors: wong lm. BJU Int. 2009 Dec;104(11):1693-5. doi: 10.1111/j.1464-410X.2009.08672.x. Epub 2009 Jun 12. BJU Int. 2009. PMID: 19522866

3

Creation and validation of a visual macroscopic hematuria scale for optimal communication and an objective hematuria index.

Wong LM, Chum JM, Maddy P, Chan ST, Travis D, Lawrentschuk N. Wong LM, et al. J Urol. 2010 Jul;184(1):231-6. doi: 10.1016/j.juro.2010.03.018. Epub 2010 May 15. J Urol. 2010. PMID: 20478586

4

A negative confirmatory biopsy among men on active surveillance for prostate cancer does not protect them from histologic grade progression.

Wong LM, Alibhai SM, Trottier G, Timilshina N, Van der Kwast T, Zlotta A, Lawrentschuk N, Kulkarni G, Hamilton R, Ferrara S, Margel D, Trachtenberg J, Jewett MA, Toi A, Evans A, Fleshner NE, Finelli A. Wong LM, et al. Eur Urol. 2014 Sep;66(3):406-13. doi: 10.1016/j.eururo.2013.04.038. Epub 2013 May 2. Eur Urol. 2014. PMID: 23664820

5

Should follow-up biopsies for men on active surveillance for prostate cancer be restricted to limited templates?

Wong LM, Trottier G, Toi A, Lawrentschuk N, Van der Kwast TH, Zlotta A, Kulkarni G, Hamilton R, Trachtenberg J, Evans A, Timilshina N, Fleshner NE, Finelli A. Wong LM, et al. Urology. 2013 Aug;82(2):405-9. doi: 10.1016/j.urology.2013.03.057. Epub 2013 Jun 2. Urology. 2013. PMID: 23735610

6

An Increase in Gleason 6 Tumor Volume While on Active Surveillance Portends a Greater Risk of Grade Reclassification with Further Followup.

Komisarenko M, Wong LM, Richard PO, Timilshina N, Toi A, Evans A, Zlotta A, Kulkarni G, Hamilton R, Fleshner N, Finelli A. Komisarenko M, et al. Among authors: wong lm. J Urol. 2016 Feb;195(2):307-12. doi: 10.1016/j.juro.2015.09.081. Epub 2015 Sep 28. J Urol. 2016. PMID: 26417646

7

Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: Establishing a dose-response relationship.

Siva S, Jackson P, Kron T, Bressel M, Lau E, Hofman M, Shaw M, Chander S, Pham D, Lawrentschuk N, Wong LM, Goad J, Foroudi F. Siva S, et al. Among authors: wong lm. Radiother Oncol. 2016 Mar;118(3):540-6. doi: 10.1016/j.radonc.2016.01.027. Epub 2016 Feb 9. Radiother Oncol. 2016. PMID: 26873790 Clinical Trial.

8

Secondary spindle cell sarcoma following external beam radiotherapy for prostate cancer: a rare but devastating complication.

Farag M, Ta A, Shankar S, Wong LM. Farag M, et al. Among authors: wong lm. BMJ Case Rep. 2018 Jul 11;2018:bcr2018225295. doi: 10.1136/bcr-2018-225295. BMJ Case Rep. 2018. PMID: 30002213 Free PMC article.

9

The role of prostate-specific membrane antigen PET/computed tomography in primary staging of prostate cancer.

Koschel S, Murphy DG, Hofman MS, Wong LM. Koschel S, et al. Among authors: wong lm. Curr Opin Urol. 2019 Nov;29(6):569-577. doi: 10.1097/MOU.0000000000000677. Curr Opin Urol. 2019. PMID: 31567440 Review.

10

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.

Hofman MS, Lawrentschuk N, Francis RJ, Tang C, Vela I, Thomas P, Rutherford N, Martin JM, Frydenberg M, Shakher R, Wong LM, Taubman K, Ting Lee S, Hsiao E, Roach P, Nottage M, Kirkwood I, Hayne D, Link E, Marusic P, Matera A, Herschtal A, Iravani A, Hicks RJ, Williams S, Murphy DG; proPSMA Study Group Collaborators. Hofman MS, et al. Among authors: wong lm. Lancet. 2020 Apr 11;395(10231):1208-1216. doi: 10.1016/S0140-6736(20)30314-7. Epub 2020 Mar 22. Lancet. 2020. PMID: 32209449 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

258 results

Search Page